QS Investors, LLC - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 48 filers reported holding ACORDA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.

Quarter-by-quarter ownership
QS Investors, LLC ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$15,000
+36.4%
21,1480.0%0.00%
Q3 2020$11,000
-84.9%
21,148
-78.7%
0.00%
-100.0%
Q2 2020$73,000
-21.5%
99,0750.0%0.00%0.0%
Q1 2020$93,000
-52.3%
99,0750.0%0.00%
-50.0%
Q4 2019$195,000
-32.3%
99,075
-1.1%
0.00%
-33.3%
Q3 2019$288,000
-62.5%
100,1890.0%0.00%
-62.5%
Q2 2019$769,000
-43.3%
100,189
-1.8%
0.01%
-46.7%
Q1 2019$1,356,000
-14.7%
101,9890.0%0.02%
-25.0%
Q4 2018$1,589,000
-20.7%
101,9890.0%0.02%
+5.3%
Q3 2018$2,004,000
-31.5%
101,9890.0%0.02%
-34.5%
Q2 2018$2,927,000
+21.4%
101,9890.0%0.03%
+16.0%
Q1 2018$2,412,000
+6.1%
101,989
-3.8%
0.02%
+19.0%
Q4 2017$2,274,000
-12.8%
106,003
-3.9%
0.02%0.0%
Q3 2017$2,608,000
+20.0%
110,2900.0%0.02%
+10.5%
Q2 2017$2,173,000
-6.2%
110,2900.0%0.02%
-5.0%
Q1 2017$2,316,000
+11.7%
110,2900.0%0.02%
+17.6%
Q4 2016$2,073,000
-10.0%
110,2900.0%0.02%
-5.6%
Q3 2016$2,303,000
-18.1%
110,2900.0%0.02%
-25.0%
Q2 2016$2,813,000
-3.6%
110,2900.0%0.02%
-14.3%
Q1 2016$2,917,000
-37.9%
110,290
+0.4%
0.03%
-37.8%
Q4 2015$4,697,000
+171.8%
109,802
+68.5%
0.04%
+150.0%
Q3 2015$1,728,000
-20.4%
65,1710.0%0.02%
-33.3%
Q2 2015$2,172,000
+0.2%
65,1710.0%0.03%
+8.0%
Q1 2015$2,168,00065,1710.02%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
ORACLE INVESTMENT MANAGEMENT INC 815,838$27,192,0003.30%
ARMISTICE CAPITAL, LLC 186,000$6,199,0002.23%
1492 Capital Management LLC 95,639$3,188,0002.02%
Partner Investment Management, L.P. 19,498$650,0000.91%
Tekla Capital Management LLC 680,862$22,693,0000.82%
PFM Health Sciences, LP 817,396$27,244,0000.69%
HighPoint Advisor Group LLC 11,829$394,0000.61%
ARBOR CAPITAL MANAGEMENT LLC 89,183$2,972,0000.56%
Pergamon Offshore Advisors, L.P. 15,950$532,0000.56%
Penn Capital Management Company, LLC 390,212$13,006,0000.54%
View complete list of ACORDA THERAPEUTICS INC shareholders